Select a Size
All Photos(3)
About This Item
Linear Formula:
(C6H10O3)n
CAS Number:
NACRES:
NA.75
PubChem Substance ID:
UNSPSC Code:
12352207
MDL number:
Product Name
Poly(2-hydroxyethyl methacrylate), BioReagent, powder, suitable for cell culture
InChI
1S/C6H10O3/c1-5(2)6(8)9-4-3-7/h7H,1,3-4H2,2H3
SMILES string
CC(=C)C(=O)OCCO
InChI key
WOBHKFSMXKNTIM-UHFFFAOYSA-N
biological source
synthetic (organic)
product line
BioReagent
form
powder
technique(s)
cell culture | mammalian: suitable
solubility
ethanol: 120 mg/mL
density
1.15 g/mL at 25 °C (lit.)
Quality Level
Looking for similar products? Visit Product Comparison Guide
Application
Poly(2-hydroxyethyl methacrylate) has been used:
- as a nonadhesive substrate in the preparation of single cell suspensions
- to implant into mice cornea for corneal micropocket assay
- to coat the well plates for sphere assay using adipose-derived mesenchymal stem cells
Biochem/physiol Actions
Poly(2-hydroxyethyl methacrylate) is an acrylic compound and has dental usage. It is mainly used to inhibit cell adhesion to growth surfaces in culture vessels.
Physical form
Water-swellable polymer. Hydrogel.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
Ignatova Tatyana N, et al.
Glia, 39(3), 193-206 (2002)
Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors
Rungarunlert S, et al.
World journal of stem cells, 1(1), 11-11 (2009)
VAP-1-Mediated M2 Macrophage Infiltration Underlies IL-1beta-but Not VEGF-A-Induced Lymph-and Angiogenesis
Nakao S, et al.
The American Journal of Pathology, 178(4), 1913-1921 (2011)
Handbook of Occupational Dermatology, 564-564 (2013)
Manuele Giuseppe Muraro et al.
Stem cells translational medicine, 1(8), 592-603 (2012-12-01)
Increasing evidence that cancers originate from small populations of so-called cancer stem cells (CSCs), capable of surviving conventional chemotherapies and regenerating the original tumor, urges the development of novel CSC-targeted treatments. Screening of new anticancer compounds is conventionally conducted on
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service